Search for: "Ranbaxy Inc. "
Results 1 - 20
of 142
Sorted by Relevance
|
Sort by Date
18 Jun 2008, 4:39 am
AP reports: Pfizer Inc. and India's Ranbaxy Laboratories Ltd. said June 18 they have settled their patent dispute over the blockbuster cholesterol drug Lipitor, delaying the release of generic versions in the U.S. until Nov. 30, 2011.Forbes gave a more complete account of the event, and noted an immediate drop in Ranbaxy stock of 5%:Under the terms of the agreement, Ranbaxy will have a license to sell generic versions of Lipitor and Caduet in the United… [read post]
8 Nov 2007, 8:01 pm
By Sherri Oslick -- Ranbaxy Laboratories, Astellas Pharma US, Inc., and Boehringer Ingelheim Corporation have announced their agreement to enter into a joint stipulation of dismissal without prejudice in their lawsuit over FLOMAX ® (tamsulosin hydrochloride, used to treat benign prostatic hyperplasia). [read post]
1 Dec 2011, 3:58 am
Yes, Virginia, Ranbaxy Will Sell A Generic Lipitor Ranbaxy to Share Part of Lipitor Profits With Teva**UPDATE. [read post]
21 Jul 2010, 9:49 pm
Pfizer Inc. et al. v. [read post]
27 Jun 2011, 4:00 am
Ranbaxy Pharmaceuticals, Inc. [read post]
13 May 2010, 9:59 pm
Medicis argued further that Ranbaxy Inc. aided, abetted,... [read post]
8 Aug 2010, 8:32 pm
• Defendants: Ranbaxy Laboratories Ltd.; Ranbaxy Pharmaceuticals Inc.; Ranbaxy, Inc.; Ethypharm S.A. [read post]
13 May 2013, 7:58 am
Ranbaxy USA, Inc., JFM-13-CR-0238 (D. [read post]
18 Jun 2008, 12:41 pm
The Lipitor Scorecard has been updated, so go and have a look at the latest results - across 23 countries.For those keen on a little pharmaceutical patent blood sport, don't despair, the battle wages on in five European counries: Finland, Spain, Portugal, Denmark and RomaniaHere's the press release from Pfizer: Pfizer and Ranbaxy Settle Lipitor Patent Litigation (mostly) Worldwide Ranbaxy to Receive License in U.S. on November 30, 2011; NEW YORK--(BUSINESS WIRE)--Pfizer… [read post]
14 May 2013, 10:50 am
Ranbaxy USA Inc., the American subsidiary of Ranbaxy Laboratories Limited, an Indian generic pharmaceutical maker, has agreed to pay $500 million to settle fines related to claims that it made false statements to the FDA about its manufacturing practices abroad and sold substandard medications and pay penalties. [read post]
23 Nov 2012, 10:40 am
Indian drugmaker Ranbaxy Laboratories said it issued the recall because of its generic version of Pfizer Inc.'s Lipitor because after it learned that some lots of its 10-, 20- and 40-milligram doses of the drug may contain glass. [read post]
21 May 2013, 2:26 pm
Earlier this month, the Department of Justice announced a $500 million settlement it reached with Ranbaxy USA Inc., a subsidiary of the Indian generic pharmaceutical manufacturer Ranbaxy Laboratories Limited. [read post]
16 Jul 2010, 8:43 am
Power-One, Inc., 2008 WL 1734833, at *12 (E.D. [read post]
25 Nov 2012, 8:36 pm
A generic form of the cholesterol lowering drug Lipitor is now being recalled by India-based Ranbaxy Pharmaceuticals Inc. because small glass particles may be in select batches. [read post]
1 Dec 2012, 8:00 pm
Separately, as to Ranbaxy's version of Lipitor ( atorvastatin ), note text from BusinessWeek in the postDrugmaker Ranbaxy halts generic Lipitor production : Problem-plagued Ranbaxy Pharmaceuticals Inc. has halted production of generic cholesterol drug Lipitor while it investigates how tiny glass particles got into the ingredients used for dozens of batches of the drug that were recalled in November. [read post]
14 Jun 2009, 8:17 pm
Ranbaxy Inc. et al. 1:09-cv-00435; filed June 11, 2009 in the District Court of Delaware Infringement of U.S. [read post]
1 Dec 2012, 8:00 pm
Separately, as to Ranbaxy's version of Lipitor ( atorvastatin ), note text from BusinessWeek in the postDrugmaker Ranbaxy halts generic Lipitor production : Problem-plagued Ranbaxy Pharmaceuticals Inc. has halted production of generic cholesterol drug Lipitor while it investigates how tiny glass particles got into the ingredients used for dozens of batches of the drug that were recalled in November. [read post]
31 Jul 2020, 4:00 pm
Pharmaceutical Manufacturer that Makes Generic Lipitor Will Pay Millions for Dangerous Drugs A subsidiary of India’s largest pharmaceutical company, Ranbaxy USA Inc, has agreed to pay the United States federal government a record $500 million in criminal and civil fines for selling adulterated drugs, including the generic version of Lipitor, and lying to regulators during the year-long investigation. [read post]
8 Jul 2012, 1:58 pm
Ranbaxy has U.S. offices in Princeton, New Jersey. [read post]
19 Aug 2007, 5:13 pm
Ranbaxy Inc. et al.3:07-cv-03755; filed August 9, 2007 in the District of Court... [read post]
